News
Gilead Sciences Inc said it won United States approval from Food and Drug Administration regulators for a drug to prevent HIV that only has to be given twice a year. That makes it a convenient new way ...
At an event in the Indian capital marking Bangladesh’s belated “Independence Day celebration,” Bangladesh’s envoy called for reimagining apparent “frosty ties.” ...
15h
NewsNation on MSNArrests of Iranian nationals increase US security concernsThe arrest of 11 Iranian nationals comes as the U.S. is on high alert for possible retaliatory attacks and sleeper cells.
5d
South Africa Today on MSNWildfires push tropical forest loss in Latin America to record highsRecent data from the University of Maryland show the tropics lost 6.7 million hectares (16.6 million acres) of primary ...
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...
1don MSN
ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...
World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...
On the eve of the International Day Against Drug Abuse and Illicit Trafficking, China released the "China Drug Situation in ...
The health concerns surrounding endocrine disruptors, such as phthalates, BPA and PFAS, can sound scary. But what we do know ...
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results